Ousia Pharma is a Danish biotech start-up focused on the development of novel peptide-drug conjugates for the treatment of metabolic diseases, utilizing a targeting approach to deliver modulators of synaptic plasticity to appetite controlling regions of the brain
Ousia Pharma is a Danish biotech start-up focused on the development of novel peptide-drug conjugates for the treatment of metabolic diseases, utilizing a targeting approach to deliver modulators of synaptic plasticity to appetite controlling regions of the brain.
The top three firms on F4's Biotech & Life Sciences investor list.